Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 16, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.31 $71.61
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 12

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,347

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 16, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.31 $150.15
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 12

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,221

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 16, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.31 $242.55
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 12

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,960

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 15, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.35 $47.00
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 11

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,008

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 15, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.35 $72.85
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 11

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,316

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 15, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.35 $152.75
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 11

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,156

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 15, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.35 $246.75
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 11

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,855

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 14, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.32 $46.40
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 10

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,988

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 14, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.32 $71.92
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 10

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,285

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 14, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.32 $150.80
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 10

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,091

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 14, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.32 $243.60
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 10

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,750

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 11, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.32 $46.40
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 9

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,968

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 11, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.32 $71.92
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 9

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,254

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 11, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.32 $150.80
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 9

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,026

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 11, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.32 $243.60
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 9

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,645

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 10, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.37 $47.40
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 8

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,948

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 10, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.37 $73.47
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 8

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,223

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 10, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.37 $154.05
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 8

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,961

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 10, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.37 $248.85
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 8

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,540

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 09, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.37 $47.40
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 7

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,928

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 09, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.37 $73.47
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 7

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,192

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 09, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.37 $154.05
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 7

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,896

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 09, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.37 $248.85
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 7

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,435

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 08, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.42 $48.40
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 6

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,908

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 08, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.42 $75.02
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 6

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,161

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 08, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.42 $157.30
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 6

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,831

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 08, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.42 $254.10
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 6

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,330

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 07, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.45 $49.00
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 5

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,888

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 07, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.45 $75.95
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 5

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,130

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 07, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.45 $159.25
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 5

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,766

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 07, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.45 $257.25
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 5

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,225

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 04, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.42 $48.40
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 4

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,868

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 04, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.42 $75.02
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 4

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,099

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 04, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.42 $157.30
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 4

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,701

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 04, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.42 $254.10
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 4

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,120

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 03, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.44 $48.80
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 3

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,848

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 03, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.44 $75.64
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 3

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,068

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 03, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.44 $158.60
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 3

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,636

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 03, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.44 $256.20
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 3

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,015

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 02, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.54 $50.80
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 2

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,828

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 02, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.54 $78.74
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 2

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,037

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 02, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.54 $165.10
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 2

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,571

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 02, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.54 $266.70
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 2

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,910

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 01, 2022 Filed Dec 23, 2022 22:05 UTC PurchaseCommon Stock 20 $2.53 $50.60
Disclosure

SEC source: 0001209191-22-062647 · doc4.xml · nonDerivative · entry 1

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,808

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 01, 2022 Filed Dec 23, 2022 22:04 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.53 $78.43
Disclosure

SEC source: 0001209191-22-062645 · doc4.xml · nonDerivative · entry 1

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,006

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 01, 2022 Filed Dec 23, 2022 22:03 UTC PurchaseCommon Stock 65 $2.53 $164.45
Disclosure

SEC source: 0001209191-22-062643 · doc4.xml · nonDerivative · entry 1

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,506

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
November 01, 2022 Filed Dec 23, 2022 22:01 UTC PurchaseCommon Stock 105 $2.53 $265.65
Disclosure

SEC source: 0001209191-22-062641 · doc4.xml · nonDerivative · entry 1

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,805

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 31, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.54 $50.80
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 25

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,788

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 31, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.54 $78.74
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 25

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,975

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 31, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.54 $165.10
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 25

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,441

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.